World News: 12:30 GMT Thursday 6th December 2018. [Pain Therapeutics, Inc. via Globe Newswire via SPi World News]
AUSTIN Texas Dec 06 2018 GLOBE NEWSWIRE -- Pain Therapeutics Inc (Nasdaq: PTIE a biopharmaceutical company announced today the initiation of a Phase II study to evaluate PTI-125 as a potential first line treatment in patients with Alzhe imer’...
Globe Newswire: 12:30 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.